Want to join the conversation?
$OREX 2Q15 Call: In June, Contrave grew to 34.3% share of the branded market vs. $32.9% in May and now is also the growing lead over the other agents. Contrave had strong Rx volume for June, 61,000 prescriptions according to IMS Health, which was up 8% vs. May performance and in 2Q15, total prescription volume was 172,000, up 47% over 1Q15.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!